Timing Optional Monitoring guidance is label-informed for semaglutide and trial-informed/pathway-based for cagrilintide
Comparative safety of pharmacologic treatments for persistent depressive disorder: a systematic review and network meta-analysis
It is the easiest way to cut through the noise and build a routine you can trust
Finally, the development of dual GLP-1/GLP-2 receptor agonists, such as dapiglutide, has shown promise in reducing intestinal transit time and increasing villus height in murine models, representing an exciting future strategy (117)
The peptide also activates alternative angiogenic pathways including VEGF-independent routes via Src-caveolin-1-eNOS signaling, providing redundant mechanisms for vascular regeneration
Elizabeth McDonald, MD, PhD, lead study author and professor of Radiology at the Hospital of the University of Pennsylvania